The Food and Drug Administration on Monday approved Cara Therapeutics's drug to treat moderate-to-severe itching in patients with chronic kidney disease undergoing dialysis, making it the first therapy for the ailment in the United States.
Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kellydrug to treat moderate-to-severe itching in patients with chronic kidney disease undergoing dialysis, making it the first therapy for the ailment in the United States.
The drug is designed to be administered three times a week after each dialysis. It reduces the activity of the sensory nerve that relays itching from the skin to the spinal cord and subsequently to the brain. Jefferies analyst Christopher Howerton estimates Korsuva will generate peak sales of about $900 million in 2030.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA could grant full approval to Pfizer/BioNTech Covid-19 vaccine today, two officials sayCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Leer más »
FDA grants full approval to Pfizer COVID-19 vaccineBREAKING: FDA grants full approval of the Pfizer COVID-19 vaccine, becoming the first COVID-19 vaccine to transition from an emergency authorization status to full FDA approval.
Leer más »
FDA grants full approval to Pfizer/BioNTech Covid-19 vaccine, opening door to more vaccine mandatesThe US Food and Drug Administration on Monday granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. This is the first coronavirus vaccine approved by the FDA, and is expected to open the door to more vaccine mandates.
Leer más »
FDA grants full approval to Pfizer's COVID-19 vaccineExperts praised the decision, saying approval could help ease some vaccine hesitancy and pave the way for more vaccination mandates.
Leer más »